BBOTBridgeBio Oncology Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 12291
Ticker: BBOT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2025-08-12
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BBOT

Detail

Enriched 2026-08-14 20:47

Market cap: $755,241,595.14
Shares outstanding (class): 80,107,104
Shares outstanding (weighted): 80,174,267
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 88
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.bridgebio.com
Description: BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Market cap and share counts drift.

Funds holding this security

11 funds · 15 positions · $19.95M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.82M	0.01%	538,049 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$2.98M	0.03%	333,485 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$2.90M	0.04%	324,513 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$2.36M	0.23%	263,669 NS	FIGI
ROYCE SMALL-CAP TRUST, INC. —	—	$1.90M	0.09%	212,359 NS	FIGI
Royce Small-Cap Fund ROYCE FUND	—	$1.62M	0.09%	180,726 NS	FIGI
ROYCE MICRO-CAP TRUST, INC. —	—	$1.32M	0.19%	147,991 NS	FIGI
Royce Micro-Cap Fund ROYCE FUND	—	$615.6K	0.19%	68,787 NS	FIGI
BlackRock Health Sciences Trust —	—	$537.3K	0.10%	60,030 NS	FIGI
Health Sciences Portfolio PACIFIC SELECT FUND	—	$363.9K	0.10%	40,663 NS	FIGI
Royce Capital Fund - Micro-Cap Portfolio ROYCE CAPITAL FUND	—	$197.0K	0.19%	22,007 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$190.2K	0.03%	21,253 NS	FIGI
Health Sciences Trust John Hancock Variable Insurance Trust	—	$87.6K	0.04%	9,785 NS	FIGI
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust	—	$58.9K	0.04%	6,580 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$4.5K	-0.00%	-500 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBBOT
FIGI_COMPOSITEBBG01L3GYF02
FIGI_SHARE_CLASSBBG01L3GYF11
CIK0001869105
ISINUS1079241022
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals based on SIC code.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.